As of the latest Form 4 filed Jul 7, 2026.
What Hims Hers Health Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 73 most recent filings for HIMS.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-06 | Okupe Oluyemi Chief Financial Officer | SSale | −7.16K | $36.49 | $261K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-06 | Okupe Oluyemi, Chief Financial Officer | MExercise | +7.16K | $5.01 | $35.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-23 | 2026-06-22 | Okupe Oluyemi Chief Financial Officer | SSale | −18.2K | $34.03 | $619K | Yes (planned) | Form 4 ↗ |
| 2026-06-23 | 2026-06-22 | Okupe Oluyemi, Chief Financial Officer | MExercise | +6.38K | $5.01 | $31.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Carroll Patrick Harrison Chief Medical Officer | SSale | −23.7K | $35.00 | $830K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-17 | Chi Michael Chief Operating Officer | SSale | −14.0K | $31.50 | $442K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-17 | Becklund Irene PAO | SSale | −4.49K | $31.50 | $141K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-17 | Elshenawy Mohamed CTO | SSale | −30.0K | $31.50 | $946K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Becklund Irene PAO | SSale | −7.57K | $30.25 | $229K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Carroll Patrick Harrison Chief Medical Officer | FTax | −8.31K | $30.17 | $251K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Carroll Patrick Harrison, Chief Medical Officer | MExercise | +25.9K | — | — | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Okupe Oluyemi Chief Financial Officer | FTax | −39.5K | $30.17 | $1.19M | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Okupe Oluyemi, Chief Financial Officer | MExercise | +71.6K | — | — | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Autor Deborah M. Chief Policy Officer | FTax | −15.4K | $30.17 | $464K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Autor Deborah M., Chief Policy Officer | MExercise | +32.9K | — | — | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Chi Michael Chief Operating Officer | FTax | −47.7K | $30.17 | $1.44M | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Chi Michael, Chief Operating Officer | MExercise | +86.3K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Becklund Irene PAO | FTax | −5.87K | $30.17 | $177K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Becklund Irene, PAO | MExercise | +16.0K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Boughton Soleil Chief Legal Officer | FTax | −23.3K | $30.17 | $703K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Boughton Soleil, Chief Legal Officer | MExercise | +42.3K | — | — | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Dudum Andrew Chief Executive Officer | FTax | −85.6K | $30.17 | $2.58M | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Dudum Andrew, Chief Executive Officer | MExercise | +155K | — | — | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Elshenawy Mohamed CTO | FTax | −152K | $30.17 | $4.57M | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Elshenawy Mohamed, CTO | MExercise | +283K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | WELLS DAVID B Director | MExercise | +957.00 | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Carroll Patrick Harrison Chief Medical Officer | MExercise | +435.00 | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Payne Christopher D Director | MExercise | +647.00 | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Payne Christopher D, Director | MExercise | +10.0K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Manuel Anja Director | MExercise | +10.0K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | WELLS DAVID B Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Schultz Kare Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Perez Garcia Andrea G Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Carroll Patrick Harrison Chief Medical Officer | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Autor Deborah M. Chief Policy Officer | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Payne Christopher D Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Pendarvis Christiane Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Manuel Anja Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Cosgrove Delos M. Director | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-26 | WELLS DAVID B Director | PPurchase | +48.4K | $24.24 | $1.17M | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Okupe Oluyemi Chief Financial Officer | SSale | −7.95K | $23.64 | $188K | Yes (planned) | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Okupe Oluyemi, Chief Financial Officer | MExercise | +7.95K | $5.01 | $39.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-20 | Okupe Oluyemi Chief Financial Officer | SSale | −19.6K | $29.96 | $589K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-20 | Okupe Oluyemi, Chief Financial Officer | MExercise | +7.00K | $11.53 | $80.7K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-20 | Okupe Oluyemi, Chief Financial Officer | MExercise | +5.55K | $5.01 | $27.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-20 | Boughton Soleil Chief Legal Officer | SSale | −9.46K | $30.00 | $284K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | Okupe Oluyemi Chief Financial Officer | SSale | −18.0K | $27.83 | $501K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | Okupe Oluyemi, Chief Financial Officer | MExercise | +6.18K | $5.01 | $31.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | Okupe Oluyemi, Chief Financial Officer | SSale | −36.9K | $25.90 | $956K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-09 | Dudum Andrew Chief Executive Officer | GGift | +423K | — | — | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-09 | Dudum Andrew, Chief Executive Officer | GGift | −423K | — | — | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | Okupe Oluyemi Chief Financial Officer | SSale | −3.98K | $19.98 | $79.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-07 | 2026-04-06 | Okupe Oluyemi, Chief Financial Officer | MExercise | +3.98K | $5.01 | $19.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-24 | 2026-03-20 | Okupe Oluyemi Chief Financial Officer | SSale | −9.22K | $23.77 | $219K | Yes (planned) | Form 4 ↗ |
| 2026-03-24 | 2026-03-20 | Okupe Oluyemi, Chief Financial Officer | MExercise | +4.49K | $5.01 | $22.5K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Chi Michael Chief Operating Officer | SSale | −97.3K | $24.69 | $2.40M | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Becklund Irene PAO | SSale | −5.53K | $24.69 | $137K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-17 | Boughton Soleil Chief Legal Officer | SSale | −4.81K | $24.69 | $119K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-03 | Baird Melissa Chief Operating Officer | SSale | −700.00 | $12.29 | $8.60K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-03 | Baird Melissa, Chief Operating Officer | SSale | −6.01K | $11.57 | $69.6K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-03 | Baird Melissa, Chief Operating Officer | SSale | −500.00 | $12.27 | $6.13K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-03 | Baird Melissa, Chief Operating Officer | SSale | −4.54K | $11.58 | $52.5K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-03 | Baird Melissa, Chief Operating Officer | MExercise | +11.8K | $0.40 | $4.70K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Baird Melissa, Chief Operating Officer | SSale | −6.71K | $12.08 | $81.1K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Baird Melissa, Chief Operating Officer | SSale | −5.04K | $12.08 | $60.8K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Baird Melissa, Chief Operating Officer | MExercise | +11.8K | $0.40 | $4.70K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Dudum Andrew Chief Executive Officer | SSale | −144K | $12.69 | $1.83M | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Dudum Andrew, Chief Executive Officer | SSale | −94.4K | $12.53 | $1.18M | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Dudum Andrew, Chief Executive Officer | SSale | −94.4K | $12.54 | $1.18M | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Dudum Andrew, Chief Executive Officer | MExercise | +189K | $2.43 | $459K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Baird Melissa Chief Operating Officer | SSale | −6.71K | $12.61 | $84.6K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Baird Melissa, Chief Operating Officer | SSale | −5.04K | $12.61 | $63.5K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Baird Melissa, Chief Operating Officer | MExercise | +11.8K | $0.40 | $4.70K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also HIMS’s full analysis or the market-wide insider trading feed. The tabs above jump to HIMS’s other SEC data.
Source: SEC Form 4 filings for HIMS, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.